申请人:Rodgers James D.
公开号:US20130045963A1
公开(公告)日:2013-02-21
The present invention provides cyclohexyl azetidine derivatives, as well as their compositions and methods of use, that modulate the activity of Janus kinase (JAK) and are useful in the treatment of diseases related to the activity of JAK including, for example, inflammatory disorders, autoimmune disorders, cancer, and other diseases.
本发明提供了环己基氮杂丙烷衍生物及其组合物和使用方法,可以调节Janus激酶(JAK)的活性,并且可用于治疗与JAK活性相关的疾病,包括炎症性疾病、自身免疫性疾病、癌症和其他疾病。